NCT04456452View on ClinicalTrials.gov

Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

September 8, 2020

Study Completion Date

November 30, 2020

Conditions
COVID-19
Interventions
BIOLOGICAL

Ampion

Ampion, administered by intravenous infusion

OTHER

Standard of Care

Standard of Care

Trial Locations (1)

80907

Research Site, Colorado Springs

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT04456452 - Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation | Biotech Hunter | Biotech Hunter